The proteome of the human breast cancer cell line MDA-MB-231: Analysis by LTQ-Orbitrap mass spectrometry

Proteomics - Clinical Applications

Volumn 3, Issue 1, 2009, Pages 41-50

  Strande, Vaïk ^a   Canelle, Ludovic ^b   Tastet, Christophe ^a   Burlet Schiltz, Odile ^b   Monsarrat, Bernard ^b   Hondermarck, Hubert ^a  

^a INSERM   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Breast cancer cells; LTQ Orbitrap

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL MEMBRANE; CELL STRAIN MDA MB 231; CELLULAR DISTRIBUTION; CLASSIFICATION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DATABASE; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

EID: 65549155430     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200800083     Document Type: Article

References (29)

1. Veronesi, U., Boyle, P., Goldhirsch, A., Orecchia, R. et al., Breast cancer. Lancet 2005, 365, 1727-1741.
2. Lacroix, M., Leclercq, G., Relevance of breast cancer cell lines as models for breast tumours: An update. Breast Cancer Res. Treat. 2004, 83, 249-289.
3. Minafra, I. P., Cancemi, P., Fontana, S., Minafra, L. et al., Expanding the protein catalogue in the proteome reference map of human breast cancer cells. Proteomics 2006, 6, 2609-2625.
4. Hardouin, J., Canelle, L., Vlieghe, C., Lasserre, J.-P. et al., Proteomic analysis of the MCF7 breast cancer cell line. Cancer Genomics Proteomics 2006, 3, 355-368.
5. Hondermarck, H., Tastet, C., El Yazidi-Belkoura, I., Toillon, R.-A. et al., Proteomics of breast cancer: The quest for markers and therapeutic targets. J. Proteome Res. 2008, 7, 1403-1411.
6. Hu, Q., Noll, R. J., Li, H., Makarov, A. et al., The Orbitrap: A new mass spectrometer. J. Mass Spectrom. 2005, 40, 430-443.
7. Scigelova, M., Makarov, A., Orbitrap mass analyzer - overview and applications in proteomics. Proteomics 2006, 6, 16-21.
8. Adachi, J., Kumar, C., Zhang, Y., Olsen, J. V. et al., The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol. 2006, 7, R80.
9. Shi, R., Kumar, C., Zougman, A., Zhang, Y. et al., Analysis of the mouse liver proteome using advanced mass spectrometry. J. Proteome Res. 2007, 8, 2963-2972.
10. Li, X., Gerber, S. A., Rudner, A. D., Beausoleil, S. A. et al., Large-scale phosphorylation analysis of alpha-factor-arrested Saccharomyces cerevisiae. J. Proteome Res. 2007, 6, 1190-1197.
11. Bouyssie, D., de Peredo, A. G., Mouton, E., Albigot, R. et al., Mascot file parsing and quantification (MFPaQ), a new software to parse, validate, and quantify proteomics data generated by ICAT and SILAC mass spectrometric analyses: Application to the proteomics study of membrane proteins from primary human endothelial cells. Mol. Cell Proteomics 2007, 6, 1621-1637.
12. Liu, H., Sadygov, R. G., Yates, J. R., III, A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 2004, 76, 4193-4201.
13. Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D. et al., Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000, 25, 25-29.
14. Stevens, S. M., Duncan, R. S., Koulen, P., Prokai, L., Proteomic analysis of mouse brain microsomes: Identification and bioinformatic characterization of endoplasmic reticulum proteins in the Mammalian central nervous system. J. Proteome Res. 2008, 7, 1046-1054.
15. Aylon, Y., Oren, M., Living with p53, dying of p53. Cell 2007, 130, 597-600.
16. Navolanic, P. M., Steelman, L. S., McCubrey, J. A., EGFR family signaling and its association with breast cancer development and resistance to chemotherapy. Int. J. Oncol. 2003, 22, 237-252.
17. Johnston, J. B., Navaratnam, S., Pitz, M. W., Maniate, J. M. et al., Targeting the EGFR pathway for cancer therapy. Curr. Med. Chem. 2006, 13, 3483-3492.
18. Ross, J. S., Fletcher, J. A., Bloom, K. J., Linette, G. P. et al., Targeted therapy in breast cancer: The HER-2/neu gene and protein. Mol. Cell. Proteomics 2004, 3, 379-398.
19. Moy, B., Kirkpatrick, P., Kar, S., Goss, P., Lapatinib. Nat. Rev. Drug Discov. 2007, 6, 431-432.
20. Vercoutter-Edouart, A. S., Lemoine, J., Le Bourhis, X., Hornez, L. et al., Proteomic analysis reveals that 14-3-3sigma is down-regulated in human breast cancer cells. Cancer Res. 2001, 61, 76-80.
21. Trask, D. K., Band, V., Zajchowski, D. A., Yaswen, P. et al., Keratins as markers that distinguish normal and tumor-derived mammary epithelial cells. Proc. Natl. Acad. Sci. USA 1990, 87, 2319-2323.
22. Overall, C. M., Tam, E. M., Kappelhoff, R., Connor, A. et al., Protease degradomics: Mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors. Biol. Chem. 2004, 385, 493-504.
23. Tam, E. M., Morrison, C. J., Wu, Y. I., Stack, M. S. et al., Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. Proc. Natl. Acad. Sci. USA 2004, 101, 6917-6922.
24. van Agthoven, T., van Agthoven, T. L., Dekker, A., van der Spek, P. J. et al., Identification of BCAR3 by a random search for genes involved in antiestrogen resistance of human breast cancer cells. EMBO J. 1998, 17, 2799-2808.
25. Brinkman, A., van der Flier, S., Kok, E. M., Dorssers, L. C., BCAR1, a human homologue of the adapter protein p130Cas, and antiestrogen resistance in breast cancer cells. J. Natl. Cancer Inst. 2000, 92, 112-120.
26. Dorssers, L. C., Grebenchtchikov, N., Brinkman, A., Look, M. P. et al., The prognostic value of BCAR1 in patients with primary breast cancer. Clin. Cancer Res. 2004, 10, 6194-6202.
27. Ong, S. E., Mann, M., Mass spectrometry-based proteomics turns quantitative. Nat. Chem. Biol. 2005, 1, 252-262.
28. Shiio, Y., Aebersold, R., Quantitative proteome analysis using isotope-coded affinity tags and mass spectrometry. Nat. Protoc. 2006, 1, 139-145.
29. Malmström, J., Lee, H., Aebersol, R., Advances in proteomic workflows for systems biology. Curr. Opin. Biotechnol. 2007, 18, 378-384.